Cargando…

Akt isoform specific effects in ovarian cancer progression

Ovarian cancer remains a significant therapeutic problem and novel, effective therapies are needed. Akt is a serine-threonine kinase that is overexpressed in numerous cancers, including ovarian. Mammalian cells express three Akt isoforms which are encoded by distinct genes. Although there are severa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Linnerth-Petrik, Nicolle M., Santry, Lisa A., Moorehead, Roger, Jücker, Manfred, Wootton, Sarah K., Petrik, Jim
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2016
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5342704/ https://www.ncbi.nlm.nih.gov/pubmed/27533079 http://dx.doi.org/10.18632/oncotarget.11204

Ejemplares similares

Opposing Functions of Akt Isoforms in Lung Tumor Initiation and Progression
por: Linnerth-Petrik, Nicolle M., et al.
Publicado: (2014)

Adeno-Associated Virus Vector Mediated Expression of an Oncogenic Retroviral Envelope Protein Induces Lung Adenocarcinomas in Immunocompetent Mice
por: Linnerth-Petrik, Nicolle M., et al.
Publicado: (2012)

Jaagsiekte sheep retrovirus detected in human lung cancer tissue arrays
por: Linnerth-Petrik, Nicolle M, et al.
Publicado: (2014)

Extracellular Matrix Proteins and Tumor Angiogenesis
por: Campbell, N. E., et al.
Publicado: (2010)

Experimental transmission of enzootic nasal adenocarcinoma in sheep
por: Walsh, Scott R, et al.
Publicado: (2013)

Quantifying Antigen-Specific T Cell Responses When Using Antigen-Agnostic Immunotherapies
por: van Vloten, Jacob P., et al.
Publicado: (2019)

Production and Purification of High-Titer Newcastle Disease Virus for Use in Preclinical Mouse Models of Cancer
por: Santry, Lisa A., et al.
Publicado: (2017)

Distinct functions of AKT isoforms in breast cancer: a comprehensive review
por: Hinz, Nico, et al.
Publicado: (2019)

ErbB2 enhances mammary tumorigenesis, oncogene-independent recurrence and metastasis in a model of IGF-IR-mediated mammary tumorigenesis
por: Campbell, Craig I, et al.
Publicado: (2010)

The thrombospondin-1 receptor CD36 is an important mediator of ovarian angiogenesis and folliculogenesis
por: Osz, Kata, et al.
Publicado: (2014)

The Role of Dysregulated Glucose Metabolism in Epithelial Ovarian Cancer
por: Kellenberger, L. D., et al.
Publicado: (2010)

Ovarian tumour growth is characterized by mevalonate pathway gene signature in an orthotopic, syngeneic model of epithelial ovarian cancer
por: Greenaway, James B., et al.
Publicado: (2016)

Characterizing Endocrine Status, Tumor Hypoxia and Immunogenicity for Therapy Success in Epithelial Ovarian Cancer
por: Pereira, Madison, et al.
Publicado: (2021)

Characteristics and outcomes of gastroduodenal ulcer bleeding: a single-centre experience in Lithuania
por: Petrik, Pavel, et al.
Publicado: (2017)

Production and purification of high-titer OrfV for preclinical studies in vaccinology and cancer therapy
por: van Vloten, Jacob P., et al.
Publicado: (2021)

Unique roles of Akt1 and Akt2 in IGF-IR mediated lung tumorigenesis
por: Franks, S. Elizabeth, et al.
Publicado: (2015)

Normalizing Tumor Vasculature to Reduce Hypoxia, Enhance Perfusion, and Optimize Therapy Uptake
por: Matuszewska, Kathy, et al.
Publicado: (2021)

Pro-apoptotic and anti-angiogenic actions of 2-methoxyestradiol and docosahexaenoic acid, the biologically derived active compounds from flaxseed diet, in preventing ovarian cancer
por: Pal, Purab, et al.
Publicado: (2019)

Oncolytic Orf virus licenses NK cells via cDC1 to activate innate and adaptive antitumor mechanisms and extends survival in a murine model of late-stage ovarian cancer
por: van Vloten, Jacob P, et al.
Publicado: (2022)

Surgical management of gastrointestinal stromal tumors: a single center experience
por: Poškus, Eligijus, et al.
Publicado: (2014)

Vertical Targeting of AKT and mTOR as Well as Dual Targeting of AKT and MEK Signaling Is Synergistic in Hepatocellular Carcinoma
por: Ewald, Florian, et al.
Publicado: (2015)

AKT in Bone Metastasis of Solid Tumors: A Comprehensive Review
por: Hinz, Nico, et al.
Publicado: (2021)

Endothelial Cell Behavior Is Determined by Receptor Clustering Induced by Thrombospondin-1
por: Morandi, Verônica, et al.
Publicado: (2021)

Loss of Akt1 or Akt2 delays mammary tumor onset and suppresses tumor growth rate in MTB-IGFIR transgenic mice
por: Watson, Katrina L, et al.
Publicado: (2013)

Characterization of the Impact of Oncolytic Vesicular Stomatitis Virus on the Trafficking, Phenotype, and Antigen Presentation Potential of Neutrophils and Their Ability to Acquire a Non-Structural Viral Protein
por: Stegelmeier, Ashley A., et al.
Publicado: (2020)

AKT isoform-specific expression and activation across cancer lineages
por: Wang, Jue, et al.
Publicado: (2018)

AAV-Vectored Expression of the Vascular Normalizing Agents 3TSR and Fc3TSR, and the Anti-Angiogenic Bevacizumab Extends Survival in a Murine Model of End-Stage Epithelial Ovarian Carcinoma
por: Stegelmeier, Ashley A., et al.
Publicado: (2022)

Mutant p53 murine oviductal epithelial cells induce progression of high-grade serous carcinoma and are most sensitive to simvastatin therapy in vitro and in vivo
por: Pereira, Madison, et al.
Publicado: (2023)

The effects of polycyclic aromatic compounds (PACs) on mammalian ovarian function
por: Perono, Genevieve A, et al.
Publicado: (2022)

Mutant p53, the Mevalonate Pathway and the Tumor Microenvironment Regulate Tumor Response to Statin Therapy
por: Pereira, Madison, et al.
Publicado: (2022)

Akt isoform-specific effects on thyroid cancer development and progression in a murine thyroid cancer model
por: Saji, Motoyasu, et al.
Publicado: (2020)

AKT Isoforms Interplay in High-Grade Serous Ovarian Cancer Prognosis and Characterization
por: Azzalini, Eros, et al.
Publicado: (2022)

A-674563, a putative AKT1 inhibitor that also suppresses CDK2 activity, inhibits human NSCLC cell growth more effectively than the pan-AKT inhibitor, MK-2206
por: Chorner, Paige M., et al.
Publicado: (2018)

AKT1 and AKT2 isoforms play distinct roles during breast cancer progression through the regulation of specific downstream proteins
por: Riggio, Marina, et al.
Publicado: (2017)

Isoform-Specific Role of Akt in Oral Squamous Cell Carcinoma
por: Roy, Nand Kishor, et al.
Publicado: (2019)

Liposomal delivery of gene therapy for ovarian cancer: a systematic review
por: Son, Jin Sung, et al.
Publicado: (2023)

Leaf physiological and morphological constraints of water-use efficiency in C(3) plants
por: Petrík, Peter, et al.
Publicado: (2023)

Quantifying Antibody Responses Induced by Antigen-Agnostic Immunotherapies
por: van Vloten, Jacob P., et al.
Publicado: (2019)

Akt isoforms in vascular disease
por: Yu, Haixiang, et al.
Publicado: (2015)

Akt isoforms in the immune system
por: Guerau-de-Arellano, Mireia, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_cu2t85tg10ooet9aomuuu4bj9o